Last reviewed · How we verify
Taro Elixir
Taro Elixir's mechanism of action is not publicly available.
At a glance
| Generic name | Taro Elixir |
|---|---|
| Sponsor | Laboratorios Goulart S.A. |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Due to lack of information, a detailed explanation of the mechanism cannot be provided.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |